The nation of Zimbabwe has turned down a major US health deal valued at $367m (£272m) over five years over the United States' demand for sensitive data.
The decision became public following a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the deal was "skewed".
An official representative has since clarified that the United States was demanding access to biological samples for scientific study and profit while refused to guarantee the resulting advantages from future treatments.
"We must now begin the difficult and regrettable process of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has appealed for continued negotiations to reach a deal suitable to both sides so the country's vital HIV programme can continue.
Wider Implications
This development follows a comparable situation in Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the security of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
USAID had overseen aid for the US government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral deals to enhance transparency and responsibility.
Based on reports, Sixteen nations in Africa have to date signed similar agreements, representing more than $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this partnership could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," the Ambassador commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, without any equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Put simply, our country would provide the raw materials for scientific discovery with no certainty that the resulting innovations would be accessible to our citizens should a future health crisis arise."
Sovereignty and Global Health
Mangwana further said that the American exit from the global health body and its push of one-on-one health agreements were upending frameworks already set up via the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing framework created to deal with potential global health emergencies.
"This framework is designed to ensure that when a nation contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
These objections over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our American counterparts on how future co-operation could be designed in a way that honours the independence and dignity of both nations."
Medical Community Response
A leading public health body expressed it understood the government's concerns, but suggested that negotiations need to persist considering a large portion of the country's HIV programmes relied on foreign aid.
"In cases where specific concerns exist, including those relating to data governance or agreement terms, these can frequently be resolved through technical clarification and negotiated safeguards," the group added.
The halted deal highlights the continuing tensions between accepting vital foreign assistance and safeguarding local interests in an increasingly interconnected world.